HRT Financial’s NEOPHOTONICS CORP NPTN Stock Holding History

HRT Financial’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,756	Closed	-$798K	–	3868
2022 Q2	$798K	Buy	+50,756	New	+$775K	0.01%	1091
2022 Q1	–	Sell	-154,739	Closed	-$2.38M	–	4166
2021 Q4	$2.38M	Buy	154,739 +88,298	+133%	+$1.16M	0.01%	573
2021 Q3	$578K	Buy	+66,441	New	+$606K	﹤0.01%	1852
2021 Q2	–	Sell	-15,114	Closed	-$180K	–	3778
2021 Q1	$180K	Sell	15,114 -14,330	-49%	-$162K	﹤0.01%	2340
2020 Q4	$267K	Buy	29,444 +17,584	+148%	+$136K	0.01%	1363
2020 Q3	$72K	Buy	+11,860	New	+$90.5K	﹤0.01%	1604

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

HRT Financial's NPTN Position: Q3 2022 in Review

HRT Financial sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 50,756 shares — an estimated $798K sold.

HRT Financial first reported a position in NPTN in Q3 2020 and held it in 6 quarters. The position peaked at $2.38M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

HRT Financial reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
HRT Financial sold 50,756 NEOPHOTONICS CORP shares in Q3 2022, an estimated $798K.
HRT Financial first reported a position in NEOPHOTONICS CORP in Q3 2020 and held it in 6 quarters.
HRT Financial's NEOPHOTONICS CORP position peaked at $2.38M in Q4 2021.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.